Research on precise immune prevention and treatment of glioma based on multi-dimensional big data

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043878

Enrollment

Unknown

Registered

2021-03-04

Start date

2021-02-28

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patients with glioma in the Department of Neurosurgery of Huashan Hospital Affiliated to Fudan University who meet the following three conditions can be enrolled 1) They were 18-80 years old, male and female; 2) The pathological diagnosis was glioma; 3) On the basis of not affecting the clinical routine diagnosis, tissue (6 mm * 6 mm) or paraffin section (5 pieces) can be used for research; 4) Sign informed consent or ethics committee approval.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will not be included in this study: 1) Participants in other clinical trials; 2) Pregnant women.

Design outcomes

Primary

Measure	Time frame
PD-L1;CTLA4;B7-H4;B7-H3;LAG-3;TIM-3;High-Throughput Sequencing (DNA, mRNA);	—

Countries

China

Contacts

Public ContactYu Yao

Department of Neurosurgery, Huashan Hospital, Fudan University

yu_yao03@126.com+86 13816391361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026